Centene stock analysis
Centene (QEN) Stock Price & Analysis
QEN Stock Chart & Stats
- Day’s Range
- EUR 62.12 - EUR 63.70
- 52-Week Range
- EUR 27.69 - EUR 68.26
- Previous Close
- EUR 63.72
- Volume
- N/A
- Average Volume (3M)
- 110
- Market Cap
- EUR 31.54B
- Enterprise Value
- EUR 46.34B
- Total Cash (Recent Filing)
- EUR 23.59B
- Total Debt (Recent Filing)
- EUR 15.54B
- Price to Earnings (P/E)
- 23.7
- Beta
- 0.24
- Next Earnings
- Feb 09, 2027 (Est.)
- EPS Estimate
- -1.03
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth
Rapid revenue expansion demonstrates strong demand across Centene’s government-sponsored and Marketplace businesses. Continued top-line growth can broaden operating scale, support investment in care-management capabilities, and provide a durable base for improving earnings if medical costs remain controlled.
Medicare Advantage Turnaround
Reaching Medicare Advantage breakeven earlier than planned signals meaningful improvement in pricing, utilization management, and execution. The expected move to better-than-breakeven results in 2027 could make the segment a more reliable contributor while Centene focuses growth on differentiated markets.
Debt Reduction
Substantial debt reduction improves financial flexibility and lowers interest expense, while eliminating near-term maturities reduces refinancing pressure. A stronger balance sheet gives Centene more capacity to fund growth, absorb medical-cost volatility, and pursue operational investments.
Bears Say
Volatile, Thin Profitability
Profitability has not yet demonstrated consistent durability despite strong revenue growth. The 2025 loss and low TTM operating margin indicate that medical utilization, execution, or other cost pressures can quickly erode earnings and limit the conversion of scale into shareholder returns.
Medicaid Membership Decline
Sustained Medicaid membership attrition can reduce premium revenue and operating scale in Centene’s largest business. Eligibility terminations and work requirements may also change member acuity, creating rate-alignment risk and making medical-cost performance harder to manage across future cycles.
PDP Margin Reset
The expected Part D margin reset shows that current segment profitability is not fully sustainable. Lower PDP margins could offset gains from enrollment growth and require continued cost-structure discipline, leaving consolidated earnings more dependent on performance in Medicaid, Marketplace, and Medicare Advantage.
Centene News
QEN FAQ
What was Centene’s price range in the past 12 months?
What is Centene’s market cap?
When is Centene’s upcoming earnings report date?
How were Centene’s earnings last quarter?
Is Centene overvalued?
Does Centene pay dividends?
What is Centene’s EPS estimate?
How many shares outstanding does Centene have?
What happened to Centene’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Centene?
What is the TipRanks Smart Score and how is it calculated?
Centene Stock Smart Score
Company Description
Centene
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Sarah McGinty London
- Employees
- 61,100
- Website
- www.centene.com
- Address
- Centene Plaza, St. Louis, MO, 63105, US
Centene (QEN) Earnings & Revenues
QEN Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Centene delivered a better-than-expected third quarter, raised 2026 adjusted EPS guidance from more than $4.80 to more than $5.20, reported strong Medicare and Marketplace performance, reached an earlier-than-expected Medicare Advantage breakeven target, reduced debt, and described multiple operating and cost-management improvements. The primary challenges were Medicaid membership declines and work-requirement-related acuity risks, expected Medicare Advantage membership contraction, Marketplace membership attrition and program-integrity costs, the planned commercial-group exit, and a likely PDP margin reset in 2027. Highlights significantly outweighed the lowlights.
View all DE:QEN earnings summariesQEN Net sales Breakdown
- 88.08% Premium
- 1.55% Service
- 10.37% Premium tax
QEN Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 5 | 1 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 12 | 0 | 0 |
